AAAAAA
Results:
1-20
|
Results: 20
Authors:
Lin, J
Johannsen, E
Robertson, E
Kieff, E
Citation: J. Lin et al., Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2, J VIROLOGY, 76(1), 2002, pp. 232-242
Authors:
Higuchi, M
Kieff, E
Izumi, KM
Citation: M. Higuchi et al., The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines, J VIROLOGY, 76(1), 2002, pp. 455-459
Authors:
Higuchi, M
Izumi, KM
Kieff, E
Citation: M. Higuchi et al., Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through TNF receptorcytoplasmic factors, P NAS US, 98(8), 2001, pp. 4675-4680
Authors:
Hung, SC
Kang, MS
Kieff, E
Citation: Sc. Hung et al., Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1, P NAS US, 98(4), 2001, pp. 1865-1870
Authors:
Han, I
Harada, S
Weaver, D
Xue, Y
Lane, W
Orstavik, S
Skalhegg, B
Kieff, E
Citation: I. Han et al., EBNA-LP associates with cellular proteins including DNA-PK and HA95, J VIROLOGY, 75(5), 2001, pp. 2475-2481
Authors:
Harada, S
Yalamanchili, R
Kieff, E
Citation: S. Harada et al., Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association, J VIROLOGY, 75(5), 2001, pp. 2482-2487
Authors:
Luftig, MA
Cahir-McFarland, E
Mosialos, G
Kieff, E
Citation: Ma. Luftig et al., Effects of the NIK aly mutation on NF-kappa B activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40, J BIOL CHEM, 276(18), 2001, pp. 14602-14606
Authors:
Callahan, J
Aster, J
Sklar, J
Kieff, E
Robertson, ES
Citation: J. Callahan et al., Intracellular forms of human NOTCH1 interact at distinctly different levels with RBP-Jkappa in human B and T cells, LEUKEMIA, 14(1), 2000, pp. 84-92
Authors:
Orstavik, S
Eide, T
Collas, P
Han, IO
Tasken, K
Kieff, E
Jahnsen, T
Skalhegg, BS
Citation: S. Orstavik et al., Identification, cloning and characterization of a novel nuclear protein, HA95, homologous to A-kinase anchoring protein 95, BIO CELL, 92(1), 2000, pp. 27-37
Authors:
Sylla, BS
Murphy, K
Cahir-McFarland, E
Lane, WS
Mosialos, G
Kieff, E
Citation: Bs. Sylla et al., The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62(dok) (Dok1) and activates NF-kappa B, P NAS US, 97(13), 2000, pp. 7470-7475
Authors:
Cahir-McFarland, ED
Davidson, DM
Schauer, SL
Duong, J
Kieff, E
Citation: Ed. Cahir-mcfarland et al., NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells, P NAS US, 97(11), 2000, pp. 6055-6060
Authors:
Wang, L
Grossman, SR
Kieff, E
Citation: L. Wang et al., Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter, P NAS US, 97(1), 2000, pp. 430-435
Authors:
Baron, S
Poast, J
Rizzo, D
McFarland, E
Kieff, E
Citation: S. Baron et al., Electroporation of antibodies, DNA, and other macromolecules into cells: ahighly efficient method, J IMMUNOL M, 242(1-2), 2000, pp. 115-126
Authors:
Ye, H
Park, YC
Kreishman, M
Kieff, E
Wu, H
Citation: H. Ye et al., The structural basis for the recognition of diverse receptor sequences by TRAF2, MOL CELL, 4(3), 1999, pp. 321-330
Authors:
Paya, CV
Fung, JJ
Nalesnik, MA
Kieff, E
Green, M
Gores, G
Habermann, TM
Wiesner, RH
Swinnen, LJ
Woodle, ES
Bromberg, JS
Citation: Cv. Paya et al., Epstein-Barr virus-induced, posttransplant lymphoproliferative disorders, TRANSPLANT, 68(10), 1999, pp. 1517-1525
Authors:
Lee, H
Choi, JK
Li, MT
Kaye, K
Kieff, E
Jung, JU
Citation: H. Lee et al., Role of cellular tumor necrosis factor receptor-associated factors in NF-kappa B activation and lymphocyte transformation by herpesvirus Saimiri STP, J VIROLOGY, 73(5), 1999, pp. 3913-3919
Authors:
Kube, D
Vockerodt, M
Weber, O
Hell, K
Wolf, J
Haier, B
Grasser, FA
Muller-Lantzsch, N
Kieff, E
Diehl, V
Tesch, H
Citation: D. Kube et al., Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428, J VIROLOGY, 73(2), 1999, pp. 1630-1636
Authors:
Izumi, KM
McFarland, EC
Riley, EA
Rizzo, D
Chen, YZ
Kieff, E
Citation: Km. Izumi et al., The residues between the two transformation effector sites of Epstein-Barrvirus latent membrane protein 1 are not critical for B-lymphocyte growth transformation, J VIROLOGY, 73(12), 1999, pp. 9908-9916
Authors:
Kaye, KM
Izumi, KM
Li, H
Johannsen, E
Davidson, D
Longnecker, R
Kieff, E
Citation: Km. Kaye et al., An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation, J VIROLOGY, 73(12), 1999, pp. 10525-10530
Authors:
Kieff, E
Shenk, T
Citation: E. Kieff et T. Shenk, Modulation of apoptosis by herpesviruses, SEMIN VIROL, 8(6), 1998, pp. 471-480
Risultati:
1-20
|